CEBPG and breast cancer: It was reported that CEBPG promoted esophageal squamous cell carcinoma progression, and the downregulation of CEBPG resulted in differentiation arrest in acute myeloid leukemia (Alberich-Jordà et al., 2012; Huang et al., 2020), although its function has still not been explored in BC.